The commercial teams of pharmaceutical companies are looking for more data analytics and business insights and they’re willing to spend more money to do it. Those are some of the findings of a recent ...

Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for all four formulations of Gobivaz - Alvotech ...

In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s amended proposal to acquire Metsera, the State of Texas’ attempt to block Kenvue’s planned dividend payment, and how data and AI are ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

The company is developing innovative therapies for rare diseases like the exon-skipping therapy VILTEPSO®. PARAMUS, N.J., Nov. 26, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma) announced a change ...

The pharmaceutical industry is experiencing a profound transformation in how it approaches commercial decision-making and insights delivery with a big wave of technology and AI at the doorstep. Market ...

Evoke Pharma, Inc. has appointed Greg Pyszczymuka to its Board of Directors as of February 20, 2025, marking the second addition to the board from Nantahala Capital Management, reflecting their ...

Marlborough-based pharmaceutical company Sumitomo Pharma America has selected executive Kenton Stewart as the firm’s inaugural chief commercial officer, effective Oct. 1. Having previously served as ...

Traditionally, pharmaceutical companies’ interactions with healthcare professionals (HCPs) have been highly personalized — primarily via face-to-face, in-office visits. Recently, however, this model ...

Ascendis Pharma (ASND) announced that YORVIPATH is now commercially available by prescription in the United States. YORVIPATH is a prodrug of parathyroid hormone, administered once-daily, designed to ...

Piramal Pharma reports ₹99 crore loss in Q2 2025 due to CDMO destocking, impacting revenue and growth prospects.

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Drafting Commercial Contracts for the Pharmaceutical Industry Training Course (Nov 12th - Nov 13th, 2025)" training has been added to ResearchAndMarkets ...